Related Experiment Video
Updated: Mar 30, 2026

10:46
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
4.5K
Evolution of Aptamer Materials Maps Exosomal Surface Proteins at the Nano-Bio Interface
Haiyan Cao1, Da Xu2, Yuming Su2
1State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Nano Letters
|March 28, 2026
Summary
We developed AptEx-ID, a new method to discover and quantify exosomal membrane proteins. This technique identifies a novel protein linked to immunotherapy response in cancer patients.
Area of Science:
- Biochemistry
- Molecular Biology
- Nanotechnology
Background:
- Exosomes are crucial nanoscale vesicles for intercellular communication.
- Interrogating exosomal membrane proteins is challenging due to their properties.
- Existing methods struggle with the hydrophobicity, low abundance, and nanoscale curvature of exosomal proteins.
Purpose of the Study:
- To develop a novel strategy for direct discovery and quantification of exosomal membrane proteins under native conditions.
- To overcome the limitations of current methods in analyzing membrane-confined epitopes.
- To identify novel exosomal biomarkers for hepatocellular carcinoma and immunotherapy response.
Main Methods:
- AptEx-ID: A chemically guided aptamer evolution strategy using indole-modified nucleotides.
- Emulation of aromatic amino acid side chains to enhance DNA's molecular interaction space.
- Fluorescence-assisted microbead display integrated with machine learning for target-agnostic probe evolution.
- Multiplexed detection workflow for comprehensive exosomal profiling.
Main Results:
- AptEx-ID successfully enabled direct discovery and quantification of exosomal membrane proteins.
- A seven-aptamer membrane signature was resolved for plasma-derived exosomes from hepatocellular carcinoma.
- GTSE1 was identified as a novel exosomal surface protein associated with immunotherapy response.
Conclusions:
- Chemically augmented nucleic acids serve as adaptive molecular materials for probing nanoscale biological membranes.
- AptEx-ID provides a powerful platform for exosomal biomarker discovery and diagnostics.
- This approach advances the understanding of exosome biology and its role in disease.

